These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2444889)
41. The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies. Panjwani A; Asfor AS; Tuthill TJ J Gen Virol; 2016 Dec; 97(12):3238-3242. PubMed ID: 27902347 [TBL] [Abstract][Full Text] [Related]
42. The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969. Monto AS; Cavallaro JJ Am J Epidemiol; 1972 Nov; 96(5):352-60. PubMed ID: 4344343 [No Abstract] [Full Text] [Related]
43. Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera. Cooney MK; Kenny GE; Tam R; Fox JP Infect Immun; 1973 Mar; 7(3):335-40. PubMed ID: 4351585 [TBL] [Abstract][Full Text] [Related]
44. Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor. Lineberger DW; Graham DJ; Tomassini JE; Colonno RJ J Virol; 1990 Jun; 64(6):2582-7. PubMed ID: 1970837 [TBL] [Abstract][Full Text] [Related]
45. Characterization of two newly recognized rhinovirus serotypes of human origin. Kapikian AZ; Mufson MA; James HD; Kalica AR; Bloom HH; Chanock RM Proc Soc Exp Biol Med; 1966; 122(4):1155-62. PubMed ID: 4288216 [No Abstract] [Full Text] [Related]
46. The major and minor group receptor families contain all but one human rhinovirus serotype. Uncapher CR; DeWitt CM; Colonno RJ Virology; 1991 Feb; 180(2):814-7. PubMed ID: 1846502 [TBL] [Abstract][Full Text] [Related]
47. Possible defense against common cold: 'block that cellular receptor site'. Marwick C JAMA; 1986 Aug 22-29; 256(8):967-8, 970-1. PubMed ID: 3016354 [No Abstract] [Full Text] [Related]
48. Picornaviruses: epitopes, canyons, and pockets. Smith TJ; Baker T Adv Virus Res; 1999; 52():1-23. PubMed ID: 10384234 [No Abstract] [Full Text] [Related]
49. Protective effect of rhinovirus receptor blocking antibody in human fibroblast cells. Sperber SJ; Hayden FG Antiviral Res; 1989 Dec; 12(5-6):231-8. PubMed ID: 2561332 [TBL] [Abstract][Full Text] [Related]
58. Rhinovirus infections in an industrial population. V. Change in distribution of serotypes. Calhoun AM; Jordan WS; Gwaltney JM Am J Epidemiol; 1974 Jan; 99(1):58-64. PubMed ID: 4359510 [No Abstract] [Full Text] [Related]
59. Antibody to rhinovirus in human sera. I. Standardization of a neutralization test. Douglas RG; Fleet WF; Cate TR; Couch RB Proc Soc Exp Biol Med; 1968 Feb; 127(2):497-502. PubMed ID: 4296290 [No Abstract] [Full Text] [Related]